Cardinal Health (CAH) has risen sharply, recording gains of 1.51% in the past 4 weeks. However, the stock has corrected -0.9% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 0.47% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
The stock has recorded a 20-day Moving Average of 0.24% and the 50-Day Moving Average is 4.13%. Cardinal Health (NYSE:CAH): On Fridays trading session , Opening price of the stock was $83.55 with an intraday high of $83.66. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $83.12. However, the stock managed to close at $83.6, a loss of 0.01% for the day. On the previous day, the stock had closed at $83.61. The total traded volume of the day was 1,025,632 shares.
The company Insiders own 0.97% of Cardinal Health shares according to the proxy statements. Institutional Investors own 84.97% of Cardinal Health shares. Also, In a research note released to the investors, Deutsche Bank maintains its rating on Cardinal Health (NYSE:CAH).The analysts at the brokerage house have a current rating of Hold on the shares. In a recent information released to the investors, Deutsche Bank raises the new price target from $83 per share to $89 per share. The rating by the firm was issued on August 4, 2016.
Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.